Table 3 Implementation of the TB related WHO packages of care for AHD patients before and after the introduction of WHO guideline for the management of Advanced HIV Disease, N = 1315
TB service provided | Overall (July 2013-Sept 2018) | Before guideline for management of AHD (Jan 2013- June 2017) n (%) | During guideline for management of AHD (July 2017-sept 2018) n (%) | P-value |
|---|---|---|---|---|
TB diagnosis | ||||
TB patient | 102 (4.8) | 45 (7.8) | 57 (8.1) | 0.852 |
Not TB patient | 1178 (88.9) | 531 (92.2) | 647 (91.9) | |
Total | 1280 | 576 | 704 | |
IPT at enrolment | ||||
Received IPT | 5 (0.6) | 4 (0.9) | 1 (0.2) | 0.155* |
No IPT | 893 (67.9) | 421 (99.1) | 472 (99.8) | |
Total | 898 | 587 | 1253 | |
Sputum Xpert as the first test for TB diagnosis | ||||
Tested | 57 (4.4) | 21 (3.7) | 36 (5.0) | 0.146 |
Not tested | 1233 (95.6) | 553 (96.3) | 680 (95.0) | |
Total | 1290 | 574 | 716 | |
Tailored counselling^ | ||||
Counselled | 16 (12.1) | 7 (10.4) | 9 (13.9) | 0.37 |
Not Counselled | 116 (87.9) | 60 (89.6) | 56 (86.2) | |
Urine LF-LAM test | ||||
Tested | 0 | 0 (0) | 0 (0) | |
Not Tested | 1275 | 564 (100) | 711 (100) | |
ART initiation (TB patients) | ||||
Less than 2 weeks | 85 (60.3) | 35 (62.5) | 50 (58.8) | < 0.398 |
More than 2 weeks | 56 (39.7) | 21 (37.5) | 35 (41.2) | |
ART initiation (non-TB patients) | ||||
Less than 2 weeks | 932 (86.3) | 381 (77.0) | 551 (94.2) | < 0.001 |
More than 2 weeks | 148 (13.7) | 114 (23.0) | 34 (5.8) | |